Companies
89bio Inc
$14.84
▲ $0.00 (+0.00%) today
Markets open · 12:07pm ET
About 89bio
89bio Inc is a biopharmaceutical company based in San Francisco, California, focusing on creating treatments for liver and cardio-metabolic diseases. Its flagship product, pegozafermin, is in development to address conditions like nonalcoholic steatohepatitis and severe hypertriglyceridemia. Founded in 2018, 89bio is at the forefront of developing innovative therapies to meet critical healthcare needs.
Frequently Asked Questions
What does 89bio do?
89bio Inc is a biopharmaceutical company based in San Francisco, California, focusing on creating treatments for liver and cardio-metabolic diseases. Its flagship product, pegozafermin, is in development to address conditions like nonalcoholic steatohepatitis and severe hypertriglyceridemia.